William McCormack

1.1k total citations
17 papers, 839 citations indexed

About

William McCormack is a scholar working on Immunology, Infectious Diseases and Surgery. According to data from OpenAlex, William McCormack has authored 17 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in William McCormack's work include Immune Response and Inflammation (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Clinical Research Studies (4 papers). William McCormack is often cited by papers focused on Immune Response and Inflammation (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Clinical Research Studies (4 papers). William McCormack collaborates with scholars based in Ireland, Australia and Singapore. William McCormack's co-authors include Andrew E. Parker, Brian Keogh, Mary M. Reilly, Luke O'neill, Peter McGuirk, Hazel Tye, Masanobu Oshima, Brendan J. Jenkins, Meri Najdovska and Patrick Tan and has published in prestigious journals such as PLoS ONE, Cancer Cell and Oncogene.

In The Last Decade

William McCormack

15 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William McCormack Ireland 11 453 238 136 124 99 17 839
Eric Tu United States 12 549 1.2× 279 1.2× 246 1.8× 102 0.8× 81 0.8× 21 1.1k
Stéphane Chappaz Australia 17 723 1.6× 285 1.2× 162 1.2× 204 1.6× 78 0.8× 24 1.2k
Gaurav Kumar United States 16 266 0.6× 223 0.9× 136 1.0× 77 0.6× 68 0.7× 48 790
Vigdis Bjerkeli Norway 18 368 0.8× 285 1.2× 107 0.8× 75 0.6× 90 0.9× 31 878
C Gasparini Italy 15 303 0.7× 251 1.1× 131 1.0× 84 0.7× 172 1.7× 25 849
Elena Maganto-García United States 14 702 1.5× 264 1.1× 221 1.6× 126 1.0× 55 0.6× 17 1.1k
Jenny Freitag Germany 8 647 1.4× 297 1.2× 111 0.8× 108 0.9× 146 1.5× 8 987
Irena Ljungcrantz Sweden 18 960 2.1× 295 1.2× 140 1.0× 159 1.3× 52 0.5× 30 1.3k
Sukriti Sukriti India 17 291 0.6× 370 1.6× 66 0.5× 84 0.7× 91 0.9× 31 1.2k

Countries citing papers authored by William McCormack

Since Specialization
Citations

This map shows the geographic impact of William McCormack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William McCormack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William McCormack more than expected).

Fields of papers citing papers by William McCormack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William McCormack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William McCormack. The network helps show where William McCormack may publish in the future.

Co-authorship network of co-authors of William McCormack

This figure shows the co-authorship network connecting the top 25 collaborators of William McCormack. A scholar is included among the top collaborators of William McCormack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William McCormack. William McCormack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Townsend, Liam, Jean Dunne, William McCormack, et al.. (2024). Immune response in vaccinated healthcare workers with frequent COVID-19 infections is characterised by blunted IFNγ and IL-2 responses to SARS-CoV-2 variants. Clinical Immunology. 268. 110371–110371. 1 indexed citations
2.
Guardiola, Jordi, Gareth Brady, William McCormack, et al.. (2024). Impact of COVID-19 vaccination on seminal and systemic inflammation in men. Journal of Reproductive Immunology. 164. 104287–104287. 1 indexed citations
3.
4.
Ghanim, Murad, John Guardiola, Gareth Brady, et al.. (2023). P-070 SARS-CoV2 antibody isotypes in seminal fluid of vaccinated men. Human Reproduction. 38(Supplement_1).
5.
Brady, Gareth, William McCormack, Adam H. Dyer, et al.. (2023). Type 1 interferon auto-antibodies are elevated in patients with decompensated liver cirrhosis. Clinical & Experimental Immunology. 215(2). 177–189.
6.
Domegan, Lisa, Cathal Walsh, Peadar Rooney, et al.. (2023). SARS-CoV-2 epidemiology, antibody dynamics, and neutralisation capacity in Irish healthcare workers in the era of booster COVID-19 vaccinations. Frontiers in Medicine. 10. 1078022–1078022. 5 indexed citations
7.
Dyer, Adam H., Isabella Batten, Emma Connolly, et al.. (2022). Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents. Journal of the American Medical Directors Association. 23(3). 434–439. 18 indexed citations
8.
Phelan, Thomas, Jean Dunne, Niall Conlon, et al.. (2021). Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity. Viruses. 13(7). 1371–1371. 11 indexed citations
9.
West, Alison C., Ke Tang, Hazel Tye, et al.. (2017). Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer. Oncogene. 36(36). 5134–5144. 53 indexed citations
10.
McDonald, Claire, Edel Hennessy, Ana Rubio‐Araiz, et al.. (2016). Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer’s disease. Brain Behavior and Immunity. 58. 191–200. 91 indexed citations
11.
Reilly, Mary M., R. Matthew Miller, Peter R. Ryle, et al.. (2013). Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody. Clinical Pharmacology & Therapeutics. 94(5). 593–600. 106 indexed citations
12.
Arslan, Fatih, Jaco H. Houtgraaf, Brian Keogh, et al.. (2012). Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs. Circulation Cardiovascular Interventions. 5(2). 279–287. 90 indexed citations
13.
Tye, Hazel, Catherine L. Kennedy, Meri Najdovska, et al.. (2012). STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation. Cancer Cell. 22(4). 466–478. 228 indexed citations
14.
15.
Saber, T., Jennifer McCormick, M. Kari Connolly, et al.. (2011). Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Research & Therapy. 13(1). R33–R33. 71 indexed citations
16.
Farrar, Conrad A., Brian Keogh, William McCormack, et al.. (2011). Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia‐reperfusion injury. The FASEB Journal. 26(2). 799–807. 70 indexed citations
17.
McCormack, William, Andrew E. Parker, & Luke O'neill. (2009). Toll-like receptors and NOD-like receptors in rheumatic diseases. Arthritis Research & Therapy. 11(5). 243–243. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Tu Breakdown of academic impact, for papers by Stéphane Chappaz Breakdown of academic impact, for papers by Gaurav Kumar Breakdown of academic impact, for papers by Vigdis Bjerkeli Breakdown of academic impact, for papers by C Gasparini Breakdown of academic impact, for papers by Elena Maganto-García Breakdown of academic impact, for papers by Jenny Freitag Breakdown of academic impact, for papers by Irena Ljungcrantz Breakdown of academic impact, for papers by Sukriti Sukriti
Rankless by CCL
2026